Contact HIV/AIDS
Info on HIV/AIDS:
206-205-7837
TTY: 206-296-4843
Toll-free: 800-678-1595
Administration:
206-296-4649
HIV/STD Testing
HIV/STD Hotline:
206-205-7837 or
Toll-free: 800-678-1595
11:00 am to 4:00 pm
Monday - Friday for
testing information, resources and referrals
|
|
HIV/AIDS Program
Bibliographies for June 2000
| 1. |
Quinn TC, Wawer MJ, Sewankambo
N et al. Viral Load and Heterosexual Transmission of Human Immunodeficiency
Virus Type 1. The New England Journal of Medicine, March
30, 2000; 342(13):921-928. |
| 2. |
Cohen, MS. Preventing Sexual
Transimission of HIV- New Ideas from Sub-Saharan Africa. The
New England Journal of Medicine, March 30, 2000; 342(13):970-972. |
| 3. |
Pinkerton SD, Abramson PR and
Holtgrave DR. What is a Condom Worth? AIDS and Behavior, 1999; 3(4):301-312. |
| 4. |
Herlitz CA and Steel JL. A
Decade of HIV/AIDS Prevention in Sweden: Changes in Attitudes Associated
with HIV and Sexual Risk Behaviour from 1987 to 1997. AIDS 2000; 14(7):881-890. |
| 5. |
Pequegnat W, Fishbein M, Celentano
D et al. NIMH/APPC Workgroup on Behavioral and Biological Outcomes
in HIV/STD Prevention Studies: A Postion Statement. Sexually
Transmitted Diseases, March 2000; 27(3):127-132. |
| 6. |
Exner TM, Gardos PS et al. HIV
Sexual Risk Reduction Interventions with Heterosexual Men: The Forgotten
Group. AIDS and Behavior, 1999; 3(4):347-358. |
| 7. |
Carey MP and Lewis BP. Motivational Strategies Can Enhance HIV Risk Reduction Programs. AIDS and Behavior, 1999; 3(4):269-276.
|
| 8. |
Kalichman SC, Browne-Sperling F and Cherry C. Effectiveness of a Video-Based Motivational Skills-Building HIV Risk-Reduction Intervention for Inner-City African American Men. Journal of Counseling and Clinical Psychology 1999; 67(6):959-966.
|
| 9. |
Thomas JC, Lansky A et al. Behaviors That Facilitate Sexual Transmission of HIV and STDs in a Rural Community. AIDS and Behavior, 1999; 3(4):257-267.
|
| 10. |
Leaity S, Sherr L et al. Repeat HIV Testing: High-Risk Behaviour or Risk Reduction Strategy? AIDS 2000; 14(5):547-552.
|
| 11. |
Bluthenthal RN, Kral AH et al. The Effect of Syringe Exchange Use on High-Risk Injection Drug Users: A Cohort Study. AIDS 2000; 14(5):605-611.
|
| 12. |
Junge B, Valente T et al. Syringe Exchange Not Associated With Social Network Formation: Results From Baltimore. AIDS 2000; 14(4):423-426.
|
| 13. |
Gorman EM and Carroll RT. Substance Abuse and HIV: Considerations With Regard to Methamphetamines and Other Recreational Drugs for Nursing Practice and Research. Journal of the Association of Nurses in AIDS Care, March/April 2000; 11(2):51-62.
|
| 14. |
Seal KH, Edlin BR et al. Risk of Hepatitis B Infection Among Young Injection Drug Users in San Francisco: Opportunities for Intervention. Western Journal of Medicine, January 2000; 172:16-20.
|
| 15. |
Hagan H. Commentary: Vaccination Could Improve Overall Health in a High Risk Population. Western Journal of Medicine, January 2000; 172:21.
|
| 16. |
Henricksen K. Harm Reduction in the Rave Community. Focus, March 2000, 15(4):1-8.
|
Sexually Transmitted Diseases
|
| 17. |
Rotchford K, Strum AW and Wilkinson D. Effects of Coinfection With STDs and of STD Treatment on HIV Shedding in Genital-Tract Secretions. Sexually Transmitted Diseases, May 2000; 27(5):243-248.
|
| 18. |
Donovan B. The Repertoire of Human Efforts to Avoid Sexually Transmissible Diseases: Past and Present. Part 1: Strategies used before or instead of Sex. Sex Transm Inf. 2000;76:7-12.
|
| 19. |
Donovan B. The Repertoire of Human Efforts to Avoid Sexually Transmissible Diseases: Past and Present. Part 2: Strategies Used During or After Sex. Sex Transm Inf 2000; 76:88-93.
|
| 20. |
Simms I and Stephenson JM. Pelvic Inflammatory Disease Epidemiology: What Do We Know and What Do We Need To Know? Sex Transm Inf 2000; 76:80-87.
|
| 21. |
CDC. Alcohol Policy and Sexually Transmitted Disease Rates-- United States, 1981-1995. Morbidity & Mortality Weekly Report, April 28, 2000; 49(16):346-349.
|
| 22. |
Chosidow O. Scabies and Pediculosis. The Lancet, March 4, 2000; 355:819-826.
|
| 23. |
Wald A, Zeh J, Selke S et al. Reactivation of Genital Herpes Simplex Virus Type 2 Infection in Asymptomatic Seropositive Persons. The New England Journal of Medicine, March 23, 2000; 342(12):844-850.
|
| 24. |
Lafferty WE, Downey L, Celum C and Wald A. Herpes Simplex Virus Type 1 as a Cause of Genital Herpes: Impact on Surveillance and Prevention. The Journal of Infectious Diseases, 2000; 181:1454-1457.
|
| 25. |
Mills J. Testing for Herpes Simplex Virus Type 2: Full-Steam Ahead. Sexually Transmitted Diseases, May 2000; 27(5):270-271.
|
| 26. |
Stanberry LR, Cunningham AL, Mindel A et al. Prospects for Control of Herpes Simplex Virus Through Immunization. Clinical Infectious Diseases, March 2000.
|
| 27. |
Hashemi FB, Ghassemi M, Faro S et al. Induction of Human Immunodeficiency Virus Type 1 Expression by Anaerobes Associated With Bacterial Vaginosis. The Journal of Infectious Diseases, 2000; 181:1574-1580.
|
| 28. |
Jones CA, Knaup RC, Hayes M, and Stoner BP. Urine Screening for Gonococcal and Chlamydia Infections at Community-Based Organizations in a High-Morbidity Area. Sexually Transmitted Diseases, March 2000; 27(3):146-151.
|
| 29. |
Gorbach PM, Aral SO, Celum C et al. To Notify or Not to Notify: STD Patients' Perspectives on Partner Notification in Seattle. Sexually Transmitted Diseases, March 2000; 27(3):193-200.
|
Men Who Have Sex With Men
|
| 30. |
Hospers HJ, Debets W, Ross M and
Kok G. Evaluation of an HIV Prevention Intervention for Men Who
Have Sex With Men at Cruising Areas in the Netherlands. AIDS
and Behavior, 1999; 3(4):359-366. |
| 31. |
Ostrow DG, Vanable PA, McKirnan
DJ and Brown LB. Hepatitis and HIV Risk Among Drug Using Men Who
Have Sex With Men: Demonstration of Hart's Law of Inverse Access and
Application to HIV. Journal of the Gay and Lesbian Medical
Association, 1999; 3(4):127-136. |
| 32. |
Cochran SD and Mays VM. Lifetime
Prevalence of Suicide Symptoms and Affective Disorders Among Men Reporting
Same-Sex Sexual Partners: Results from NHANES III. American
Journal of Public Health, April 2000; 90(4):573-578. |
| 33. |
Davidovich, U, de Wit JBF and
Stroebe W. Assessing Sexual Risk Behavior of Young Gay Men in Primary
Relationships: The Incorporation of Negotiated Safety and Negotiated
Safety Compliance. AIDS 2000; 14(6):701-706. |
| 34. |
Mutchler, M. Making Space for
Safer Sex. AIDS Education and Prevention 2000, 12(1):1-14. |
| 35. |
Miller M, Meyer L, Boufassa F et al. Sexual Behavior Changes and Protease Inhibitor Therapy. AIDS 2000; 14(4):F33-F39.
|
| 36. |
Lampinen TM, Critchlow CW, Kuypers JM et al. Association of Antiretroviral Therapy With Detection of HIV-1 RNA and DNA in the Anorectal Mucosa of Homosexual Men. AIDS 2000; 14(4):F69-F75.
|
| 37. |
Ciemins EL, Flood J, Kent CK et al. Reexamining the Prevalence of Chlamydia Trachomatis Infection Among Gay Men with Urethritis. Sexually Transmitted Diseases, May 2000; 27(3):249-251.
|
| 38. |
Akukwe C. HIV/AIDS in African Children: A Major Calamity That Deserves Urgent Global Action. Journal of HIV/AIDS Prevention & Education for Adolescents and Children 1999; 3(3):5-24.
|
| 39. |
Gibb DM. Antenatal Screening for HIV Infection. AIDS Patient Care and STDs 2000, 14(3):125-131.
|
| 40. |
Gibb DM, Newberry A, de Rossi A et al. Immune Repopulation After HAART In Previously Untreated HIV-1 Infected Children. The Lancet, 15 April 2000; 355:1331-1332.
|
| 41. |
Welner SL. Sexually Transmitted Infections in Women With Disabilities- Diagnosis, Treatment and Prevention: A Review. Sexually Transmitted Diseases, May 2000; 27(5):272-277.
|
| 42. |
Russell LD, Alexander MK and Corbo KF. Developing Culture-Specific Interventions for Latinas to Reduce HIV High-Risk Behaviors. Journal of the Association of Nurses in AIDS Care, May/June 2000; 11(3):70-76.
|
| 43. |
Brown JE and Brown RC. Traditional Intravaginal Practices and the Heterosexual Transmission of Diseases. Sexually Transmitted Diseases, April 2000; 27(4):183-187.
|
| 44. |
Cohen M, Deamant C, Barkan S et al. Domestic Violence and Childhood Sexual Abuse in HIV-Infected Women and Women at Risk for HIV. American Journal of Public Health, April 2000; 90(4):560-565.
|
| 45. |
Cu-Uvin S, Caliendo AM, Reinert S et al. Effect of Highly Active Antiretroviral Therapy on Cervicovavaginal HIV-1 RNA. AIDS 2000; 14(4):415-421.
|
| 46. |
Wong M, Chan RKW, Koh D and Wee S. A Prospective Study on Comdom Slippage and Breakage Among Female Brothel-Based Sex Workers in Singapore. Sexually Transmitted Diseases, April 2000; 27(4):208-214.
|
| 47. |
Rotheram-Borus MJ and Futterman
D. Promoting Early Detection of Human Immunodeficiency Virus Infection
Among Adolescents. Archives of Pediatric and Adolescent Medicine, May 2000; 154:435-439. |
| 48. |
Ellen JM, Lane MA and McCright
J. Are Adolescents Being Screened For Sexually Transmitted Diseases?
A Study of Low Income African Amearican Adolescents in San Francisco. Sexually Transmitted Infections, 2000; 76:94-97. |
| 49. |
Bok M and Morales J. Harm Reduction:
Dealing Differently With Adolescents and Youth. Journal of
HIV/AIDS Prevention & Education for Adolescents and Children, 1999; 3(3):87-99. |
| 50. |
Whitaker DJ and Miller KS. Parent-Adolescent
Discussions About Sex and Condoms: Impact on Peer Imfluences of Sexual
Risk Behavior. Journal of Adolescent Research, March 2000;
15(2):251-273. |
| 51. |
Pack RP, DiClemente RJ, Hook EW
and Oh MK. High Prevalence of Asymptomatic STDs in Incarcerated
Minority Male Youth. Sexually Transmitted Diseases, March
2000; 27(3):175-177. |
| 52. |
Kirby D. Making Condoms Available
in Schools: The Evidence is Not Conclusive. Western Journal
of Medicine, March 2000; 172:149-151. |
| 53. |
Suss Al, Homel P, Hammerschlag
M and Bromberg K. Risk Factors for Pelvic Inflammatory Disease
in Inner-City Adolescents. Sexually Transmitted Diseases, May
2000; 27(5):289-291. |
| 54. |
Robinson FP, Matthews HL and Witek-Janusek
L. Stress Reduction and HIV Disease: A review of Intervention Studies
Using Psychoneuroimmunology Framework. Journal of the Association
of Nurses in AIDS Care, March/April 2000; 11(2):87-96. |
| 55. |
Aranda-Naranjo B, Gaskins S, Bustamante
L et al. La Desesperation: Migrant and Seasonal Farm Workers Living
with AIDS/HIV. Journal of the Association of Nurses in AIDS
Care, March/April 2000; 11(2):22-28. |
| 56. |
Jeffe DB, Khan SR, Meredith KL
et al. Disclosure of HIV Status to Medical Providers: Differences
by Gender, Race, and Immune Function. Public Health Reports, January/February 2000; 115:38-45. |
| 57. |
Erbelding EJ, Stanton D, Quinn
TC and Rompalo A. Behavioral and Biologic Evidence of Persistent
High-Risk Behavior in an HIV Primary Care Population. AIDS
2000; 14(3):297-301. |
| 58. |
Hahn Bh, Shaw GM, De Cock KM and
Sharp PM. AIDS as a Zoonosis: Scientific and Public Health Implications. Science, January 28, 2000; 287:607-614. |
| 59. |
Clifford, DB. Human Immunodeficiency
Virus-Associated Dementia. Archives of Neurology, March
2000; 57:321-324. |
| 60. |
Antman K and Chang Y. Kaposi's
Sarcoma. New England Journal of Medicine, April 6, 2000;
342 (14):1027-1038. |
| 61. |
Lyon DE and Truban E. HIV-Related
Lipodystrophy: A Clinical syndrome With Implications for Nursing Practice. Journal of the Association of Nurses in AIDS Care, March/April
2000; 11(2):36-42. |
| 62. |
Rerkpattanapipat P, Wongpraparut
N, Jacobs LE and Kotler MN. Cardiac Manifestations of Acquired
Immunodeficiency Syndrome. Archives of Internal Medicine, March
13, 2000; 160:602-608. |
| 63. |
El-Sadr WM, Burman W, Bjorling-Grant
L, et al. Discontinuation of Prophylaxis against Mycobacterium
Avium Complex Disease in HIV-Infected Patients Who Have a Response
to Antiretroviral Thera;y. New England Journal of Medicine, April 13, 2000;342(15):1085-1092. |
| 64. |
Kovacs JA and Masur H. Prophxylaxis
Against Opportunistic Infections in Patients With Human Immunodeficiency
Virus Infection. New England Journal of Medicine, May 11,
2000 ;342(19):1416-1429. |
Anti-Retroviral Treatment
|
| 65. |
Blower SM, Gershengorn HB and
Grant RM. A Tale of Two Futures: HIV and Antiretroviral Therapy
In San Francisco. Science, January 28, 2000; 287:650-654. |
| 66. |
Paredes R, Mocroft A, Kirk O et
al. Predictors of Virological Success and Ensuing Failure in HIV-Positive
Patients Starting Highly Active Antiretroviral Therapy in Europe:
Results From the EuroSIDA Study. Archives of Internal Medicine, April 24, 2000; 160:1123-1132. |
| 67. |
Al-Harthi L, Siegel J, Spritzler
J et al. Maximum Suppression of HIV Replication Leads to the Restoration
of HIV-Specific Responses in Early HIV Disease. AIDS 2000; 14(7):761-770. |
| 68. |
Yerly S, Kaiser L, Perneger TV
et al. Time of Initiation of Antiretroviral Therapy: Impact on
HIV-1Viraemia. AIDS 2000; 14(3):243-249. |
| 69. |
Eron JJ, Smeaton LM, Fiscus SA
et al. The Effects of Protease Inhibitor Therapy on Human Immunodeficiency
Virus Type 1 Levels in Semen (AIDS Clinical Trials Group Protocol
850). The Journal of Infectious Diseases, 2000; 181:1622-1628. |
| 70. |
Hirsh MS, Brun-Vèzinet
F, D'Aquila RT et al. Antiretroviral Drug Resistance Testing in
Adult HIV-1 Infection: Recommendations of an Interantional AIDS Society-USA
Panel. Journal of the American Medical Association, May
10, 2000; 283(18):2417-2426. |
| 71. |
Flexner C. HIV Genotype and
Phenotype- Arresting Resistance? Journal of the American Medical
Association, May 10, 2000; 283(18):2442-2444. |
| 72. |
Ruiz L, Martinez-Picado J, Romeu
J et al. Structured Treatment Interruption in Chronically HIV-1
Infected Patients After Long-Term Viral Supression. AIDS 2000;
14:397-403. |
| 73. |
Lambotte O, Taoufik Y, de Göer
MG et al. Detection of Infectious HIV in Circulating Monocytes
From Patients on Prolonged Highly Active Antiretroviral Therapy. Journal
of Acquired Immune Deficiency Syndromes, February 1, 2000; 23(2):114-119. |
| 74. |
Johnston-Roberts K. Barriers to and Facilitators of HIV-Positive Patients' Adherence to Antiretroviral Treatment Regimens. AIDS Patient Care and STDs, 2000; 14(3):155-167.
|
| 75. |
Bangsberg DR, Hecht FM, Charlebois ED et al. Adherence to Protease Inhibitors, HIV-1 Viral Load, and Development of Drug Resistance in an Indigent Population. AIDS 2000; 14(4):357-366.
|
| 76. |
Bamberger JD, Unick J, Klein P et al. Helping the Urban Poor Stay With Antiretroviral HIV Drug Therapy. American Journal of Public Health, May 2000; 90(5):699-701.
|
|
|
|
